You just read:

LLS Applauds FDA Approval of New Targeted Therapy for Acute Myeloid Leukemia as a Significant Advance for Deadly Blood Cancer

News provided by

The Leukemia & Lymphoma Society

Aug 01, 2017, 15:49 ET